Shares of CONMED Co. (NYSE:CNMD – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective […]
CONMED (NYSE:CNMD – Free Report) had its price target lowered by Piper Sandler from $100.00 to $95.00 in a research note published on Thursday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research analysts have also commented on the company. Needham & Company LLC decreased their […]
CONMED (NYSE:CNMD – Free Report) had its target price reduced by JPMorgan Chase & Co. from $115.00 to $75.00 in a report published on Thursday, Benzinga reports. They currently have an overweight rating on the stock. CNMD has been the subject of a number of other research reports. Needham & Company LLC decreased their price […]
CONMED (NYSE:CNMD – Free Report) had its price objective cut by Piper Sandler from $100.00 to $95.00 in a report issued on Thursday, Benzinga reports. They currently have an overweight rating on the stock. A number of other research firms have also recently issued reports on CNMD. JPMorgan Chase & Co. reduced their target price […]
CONMED (NYSE:CNMD – Free Report) had its price target trimmed by Wells Fargo & Company from $98.00 to $77.00 in a report released on Thursday, Benzinga reports. The firm currently has an equal weight rating on the stock. CNMD has been the subject of several other research reports. Needham & Company LLC decreased their target […]